Skip to main content
OpenTrials

Clinical trial condition

Renal Cell Carcinoma (RCC) (Phase ll Only)

Explore clinical trials studying Renal Cell Carcinoma (RCC) (Phase ll Only). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Renal Cell Carcinoma (RCC) (Phase ll Only) trial results

Completed

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

NCT02335918

Conditions
Adenocarcinoma, Astrocytoma, Carcinoma, +37 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • The Stanford Center for Clinical and Translational Education and Research Palo Alto, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Medical Center Aurora, Colorado, United States
View all 19 locations
View Trial Details

Related conditions